In Vitro and In Vivo Inhibition of MRP Gene Expression and Reversal of Multidrug Resistance by siRNA

Basic and Clinical Pharmacology and Toxicology

Volumn 108, Issue 3, 2011, Pages 177-184

  Wu, Zhuo ^a   Li, Xiaobo ^b   Zeng, Yanyan ^c   Zhuang, Xiaoming ^d   Shen, Hong ^c   Zhu, Haiqing ^c   Liu, Hongyi ^c   Xiao, Hong ^c  

^a FUDAN UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c THE AFFILIATED BRAIN HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIRUBICIN; LIPOFECTAMINE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE EXPRESSION; GENE SILENCING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ELECTROPORATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPIDS; MALE; MICE; MICE, NUDE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASMS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79951763915     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2010.00642.x     Document Type: Article

References (28)

1. Dykxhoorn DM, Palliser D, Lieberman J. The silent treatment: siRNAs as small molecule drugs. Gene Ther 2006;13:541-52.
2. Dykxhoorn DM, Lieberman J. Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs. Annu Rev Biomed Eng 2006;8:377-402.
3. Bumcrot D, Manoharan M, Koteliansky V, Sah WYD. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol 2006;2:711-9.
4. Masiero M, Nardo G, Indraccolo S, Favaro E. RNA interference: Implications for cancer treatment. Mol Aspects Med 2007;28:143-66.
5. Dykxhoorn DM, Lieberman J. Knocking down disease with siRNAs. Cell 2006;126:231-5.
6. Pai SI, Lin YY, Macaes B, Meneshian A, Hung CF, Wu TC. Prospects of RNA interference therapy for cancer. Gene Ther 2006;13:464-77.
7. Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 2001;15:188-200.
8. Prechtel AT, Turza NM, Theodoridis AA, Kummer M, Steinkasserer A. Small interfering RNA(siRNA) delivery into monocyte-derived dendritic cells by electroporation. J Immunol Methods 2006;311:139-52.
9. Mir LM, Bureau MF, Gehl J, Rangara R, Rouy D, Caillaud JM et al. High-efficiency gene transfer into skeletal muscles mediated by electricpulses. Proc Natl Acad Sci 1999;96:4262-7.
10. Lewis DL, Hagstorm JE, Loomis AG, Wolff JA, Herweijer H. Efficient delivery siRNA for inhibition of gene expression in postnatal mice. Nat Genet 2002;32:107-8.
11. Yang PL, Althage A, Chung J, Chisari FC. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci 2002;99:13825-30.
12. Heller LC, Ugen K, Heller R. Electroporation for targeted gene transfer. Expert Opin Drug Deliv 2005;2:255-68.
13. Li S. Electroporation gene therapy: new developments in vivo and in vitro. Curr Gene Therapy 2004;4:309-16.
14. Wells DJ. Gene therapy progress and prospects: electroporation and other physical methods. Gene Ther 2004;11:1363-9.
15. Golzio M, Mazzolini L, Ledoux A, Paganin A, Izard M, Hellaudais L et al. In vivo gene silencing in solid tumor by targeted electrically mediated siRNA delivery. Gene Ther 2007;14:752-9.
16. Gottesman MM, Fojo T, Bates SE. Multidrug resistence in cancer: role of ATP-dependent transporters. Nat Rew Cancer 2002;2:48-58.
17. Ricardo PT. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Curr Med Chem 2006;13:1859-76.
18. TMRNAi. Basic Clin Pharmacol 2008;103:342-8.
19. Takei Y, Kadomatsu K, Yuzawa Y, Matsuo S, Muramatsu T. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res 2004;64:3365-70.
20. Tiscornia G, Singer O, Ikawa M, Verma IM. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Nat Acad Sci 2003;100:1844-8.
21. Bantounas I, Phylactou LA, Uney JB. RNA interference and the use of small interfering RNA to study gene function in mammalian systems. J Mol Endocrinol 2004;33:545-57.
22. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M. Electrochemotherapy in treatment of tumors. Eur J Surg Oncol 2008;34:232-40.
23. Takei Y, Nemoto T, Mu P, Fujishima T, Ishimoto T, Fujishima T et al. In vivo silencing of a molecular target by short interfering RNA electroporation: tumor vascularization correlates to delivery efficiency. Mol Cancer Ther 2008;7:211-21.
24. Omi K, Tokunaga K, Hohjoh H. Long-lasting RNAi activity in mammalian neurons. FEBS Lett 2004;558:85-95.
25. Jacque JM, Triques K, Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature (Lond.) 2002;418:435-8.
26. Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, Lee SK et al. siRNA-directed inhibition of HIV-1 infection Nat Med 2002;8:681-6.
27. McManus MT, Sharp PA. Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002;3:737-47.
28. Rols MP, Delteil C, Golzio M, Dumond P, Cros S, Teissie J. In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 1998;16:168-71.